The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: A cohort study

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 425-432

  Wong, Martin C S ^a   Tam, Wilson W S ^a   Lao, X Q ^a   Wang, Harry H X ^a   Kwan, Mandy W M ^a   Cheung, Clement S K ^b   Tong, Ellen L H ^b   Cheung, N T ^b   Yan, Bryan P ^a   Yu, C M ^a   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

Adherence; Atenolol; Blood pressure control; First line antihypertensive; Metoprolol; blockers

Indexed keywords

ATENOLOL; METOPROLOL TARTRATE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHINESE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HONG KONG; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; ETHNOLOGY; FOLLOW UP; HEALTH SURVEY; MORTALITY; PROCEDURES; TREATMENT OUTCOME;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATENOLOL; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; MALE; METOPROLOL; MIDDLE AGED; POPULATION SURVEILLANCE; TREATMENT OUTCOME;

EID: 84905110068     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.009     Document Type: Article

References (46)

1. C.M. Lawes, S.V. Hoorn, A. Rodgers, and International Society of Hypertension Global burden of blood-pressure-related disease, 2001 Lancet 371 2008 1513 1518
2. J.A. Cutler, P.D. Sorlie, M. Wolz, T. Thom, L.E. Fields, and E.J. Roccella Trends in hypertension prevalence, awareness, treatment, and control rates in the United States adults between 1988-1994 and 1999-2004 Hypertension 52 2008 818 827
3. D.M. Lloyd-Jones, R. Adams, and M. Carnethon et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee Circulation 119 2009 e21 e181
4. K. Wolf-Maier, R.S. Cooper, and H. Kramer et al. Hypertension treatment and control in five European countries, Canada, and the United States Hypertension 43 2004 10 17
5. T. Dorjgochoo, X.O. Shu, and Z. Zhang et al. Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study Hypertension 27 2009 468 475
6. Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomize trials Br Med J 336 2008 1121 1123
7. N.M. Kaplan, and R.G. Victor In Chapter 7 Treatment of hypertension: drug therapy Kaplan's Clinical Hypertension 10th ed. 2010 Lippincott Williams & Wilkins 192 273 [a Wolters Kluwer business]
8. A.V. Chobanian, G.L. Bakris, and H.R. Black et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and the treatment of high blood pressure Hypertension 42 2003 1206 1252
9. G. Mancia, S. Laurent, and E. Agabiti-Rosei et al. Reappraisal of European guidelines on hypertension management: European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
10. National Collaborating Centre for Chronic Conditions Hypertension: clinical management of primary hypertension in adults. NICE guideline draft (February 2011) Available at http://www.nice.org.uk/nicemedia/live/12167/53225/ 53225.pdf [Accessed 06 December, 2013]
11. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol Lancet 359 2002 995 1003
12. B. Dahlof, P.S. Sever, and N.R. Poulter et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial Lancet 366 2005 895 906
13. L.H. Lindholm, B. Carlberg, and O. Samuelsson Should beta-blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 2005 1545 1553
14. C.S. Wiysonge, H. Bradley, and B.M. Mayosi et al. Beta-blockers for hypertension Cochrane Database Syst Rev 1 2007 CD002003
15. D.G. Beevers The end of beta blockers for uncomplicated hypertension? Lancet 366 2005 1510 1512
16. H.T. Ong Beta blockers in hypertension and cardiovascular disease BMJ 334 2007 946 949
17. M.C.S. Wong, W.W. Tam, and C.S. Cheung et al. Antihypertensive prescriptions over a 10-year period in a large Chinese population Am J Hypertens 26 2013 931 938
18. M.C.S. Wong, W.W. Tam, and C.S. Cheung et al. Medication adherence to first-line antihypertensive drug class in a large Chinese population Int J Cardiol 167 2013 1438 1442
19. M.C.S. Wong, W.W.S. Tam, and C.S.K. Cheung et al. Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study Int J Cardiol 168 2013 928 933
20. M.C.S. Wong, W.W.S. Tam, and H.H.X. Wang et al. Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study Int J Cardiol 168 2013 4705 4710
21. M.C.S. Wong, Y. Jiang, J.L. Tang, A. Lam, H. Fung, and S.W. Mercer Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data BMC Health Serv Res 8 2008 138
22. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Factors associated with compliance to thiazide diuretics among 8551 Chinese patients J Clin Pharm Ther 36 2011 179 186
23. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Adherence to combination therapy among ethnic Chinese patients: a cohort study Hypertens Res 33 2010 416 421
24. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study Clin Ther 31 2009 2170 2177
25. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study J Clin Pharmacol 50 2010 598 605
26. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients Am J Hypertens 22 2009 904 910
27. W. Sun, M. Schooling, W.M. Chan, K.S. Ho, and T.H. Lam The association between depressive symptoms and mortality among Chinese elderly: a Hong Kong cohort study J. Gerontol A Biol Sci Med Sci 66A 2011 459 466
28. C.M. Schooling, T.H. Lam, and Z.B. Li et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort Arch Intern Med 166 2006 1498 1504
29. T.H. Lam, S.Y. Ho, A.J. Hedley, K.H. Mak, and R. Peto Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998 BMJ 323 2001 361
30. N.K. Choudhry, W.H. Shrank, and R.L. Levin et al. Measuring concurrent adherence to multiple related medications Am J Manag Care 15 2009 457 464
31. B.C. Martin, E.K. Wiley-Exley, S. Richards, M.E. Domino, T.S. Carey, and B.L. Sleath Contrasting measures of adherence with sampling drug use, medication switching and therapeutic duplication Ann Pharmacother 43 2009 36 44
32. S.E. Andrade, K.H. Kahler, F. Frech, and K.A. Chan Methods for evaluation of medication adherence and persistence using automated databases Pharmacoepidemiol Drug Saf 15 2006 565 574
33. G. Mazzaglia, E. Ambrosioni, and M. Alacqua et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients Circulation 120 2009 1598 1605
34. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
35. S.E. Andrade, K.H. Kahler, F. Frech, and K.A. Chan Methods for evaluation of medication adherence and persistence using automated databases Pharmacoepidemiol Drug Saf 15 2006 565 574
36. T.A. Burke, M.C. Sturkenboom, S. Lu, C.E. Wentworth, Y. Lin, and G.G. Rhoads Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice J Hypertens 24 2006 1193 1200
37. G. Mazzaglia, L.G. Mantovani, and M.C. Sturkenboom et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care J Hypertens 23 2005 2093 2100
38. M.C. Wong, W.W. Tam, and C.S. Cheung et al. Initial antihypertensive prescription and switching: a 5 year cohort study from 250,851 patients PLoS One 8 2013 e53625
39. I.A. Dhalla, T. Gomes, and Z. Yao et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults Ann Intern Med 158 2013 447 455
40. L.H. Curtis, B.G. Hammill, E.L. Eisenstein, J.M. Kramer, and K.J. Anstrom Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases Med Care 45 2007 S103 S107
41. R.B. D'Agostino Propensity scores in cardiovascular research Circulation 115 2007 2340 2343
42. S. Schneeweiss, J.A. Rassen, R.J. Glynn, J. Avorn, H. Mogun, and M.A. Brookhart High-dimensional propensity score adjustment in studies of treatment effects using health care claims data Epidemiology 20 2009 512 522
43. T. Gomes, D.N. Juurlink, J.M. Ho, S. Schneeweiss, and M.M. Mamdani Risk of serious falls associated with oxybutynin and tolterodine: a population based study J Urol 186 2011 1340 1344
44. E.D. Parkers, K.L. Margolis, and N.K. Trower et al. Comparative effectiveness of 2 β-blockers in hypertensive patients Arch Intern Med 172 2012 1406 1412
45. M.J. Brown Hypertension and ethnic group BMJ 332 2006 833 836
46. AHFS Drug Information G.K. McEvoy, Atenolol 2005 American Society of Health-System Pharmacists Bethesda, MD 1755 1762